Медико-биологический
информационный портал
для специалистов
 
БИОМЕДИЦИНСКИЙ ЖУРНАЛ Medline.ru

СОДЕРЖАНИЕ ЖУРНАЛА:
Физико-химическая биология

Клиническая медицина

Профилактическая медицина

Медико-биологические науки


АРХИВ:

Фундаментальные исследования

Организация здравохраниения

История медицины и биологии



Последние публикации

Поиск публикаций

Articles

Архив :  2000 г.  2001 г.  2002 г. 
               2003 г.  2004 г.  2005 г. 
               2006 г.  2007 г.  2008 г. 
               2009 г.  2010 г.  2011 г. 
               2012 г.  2013 г.  2014 г. 
               2015 г.  2016 г.  2017 г. 
               2018 г.  2019 г. 

Редакционная информация:
        Опубликовать статью
        Наша статистика


 РЕДАКЦИЯ:
Главный редактор

Заместители главного редактора

Члены редколлегии
Специализированные редколлегии


 УЧРЕДИТЕЛИ:
Федеральное государственное бюджетное учреждение науки
"Институт токсикологии Федерального медико-биологического агентства"
(ФГБУН ИТ ФМБА России)

Институт теоретической и экспериментальной биофизики Российской академии наук.

ООО "ИЦ КОМКОН".




Адрес редакции и реквизиты

199406, Санкт-Петербург, ул.Гаванская, д. 49, корп.2

ISSN 1999-6314

Российская поисковая система
Искать: 


«
Vol. 12, Art. 23 (pp. 261-289)    |    mart 2011       

№ гос. регистрации: 0421100002\0023
»

Bronchial asthma and smoking
VV Gnoevyh, AJ Smirnov, YS Nagornov, EA Shalashova,
AA Kupriyanov, Y. Portnova

Ulyanovsk State University



Brief summary

Tobacco smoking in bronchial asthma patients expands the inflammation of small airways, worsens lung function, affects negatively the transport of oxygen, causes the adaptive changes of morphological and functional erythrocyte parameters, enhances the arising dysfunctions of autonomic nervous system, reduces asthma control.


Key words

bronchial asthma, tobacco smoking, pulmocardiology dysfunctions, asthma control.





(The article in PDF format. For preview need Adobe Acrobat Reader)



Open article in new window

Reference list

1. Antonov N.S. Epidemiologiya bronholegochnih zabolevanii v Rossii // Pylmonologiya, 2006.-4.-83-8;


2. Belevskii A.S. Test kontrolya astmi – «novaya igryshka» ili vajnii instryment // Atmosfera. Pylmonologiya i allergologiya, 2005.-1.-33-4;


3. Bilichenko T.N., Baldyeva M.F. Znachimost izmereniya okisi azota vidihaemogo vozdyha pri boleznyah organov dihaniya // Pylmonologiya, 2006.-6.- 118-22;


4. Bilichenko T. N. Bronhialnaya astma. Pod red. A. G. Chychalina, M.: 1997.-458;


5. Brimkylov N.N., Vinnikov D.V. Osobennosti tabachnoi zavisimosti y pacientov s hronicheskoi obstryktivnoi boleznu legkih // Pylmonologiya, 2002.-№4.-21-4;


6. Vinickaya R.S. Kapnografiya v diagnostike lyogochnoi nedostatochnosti, 2002.- http://www.medlinks.ru/article.php?sid=5835;


7. Geppe N.A. Sovremennie predstavleniya o taktike lecheniya bronhialnoi astmi y detei // RMJ, 2002.- t.10. -7.- 353-58;


8. Globalnaya strategiya lecheniya i profilaktiki bronhialnoi astmi. Peresmotr 2006. Rysskaya versiya pod redakciei akademika RAMN Chychalina A.G. M.: «Atmosfera», 2007.-1-160;


9. Globalnaya strategiya lecheniya i profilaktiki bronhialnoi astmi. Peresmotr 2007. Rysskaya versiya pod redakciei akademika RAMN Chychalina A.G. M.: «Atmosfera», 2008.-1-160;


10. Globalnaya strategiya lecheniya i profilaktiki bronhialnoi astmi. (Global Initiative for Asthma, GINA), peresmotr 2009 g. (http://www.ginasthma.org.);


11.Gnoevih V.V. Effektivnost adaptacii respiratornoi sistemi k kyreniu y stydentov medicinskih vyzov pri nikotinassociirovannom riske hronicheskoi obstryktivnoi bolezni legkih // Pylmonologiya, 2005.- t.15.-№3.-69-73;


12. Gnoevih V.V. Nikotininassociirovannie osobennosti kachestva jizni y bolnih bronhialnoi astmoi molodogo vozrasta/V.V. Gnoevih, V.A. Semenov, E.A. Shalashova // Izvestiya visshih ychebnih zavedenii. Povoljskii region. Seriya «Medicinskie nayki», 2006.-№ 1 (22).-81-91;


13. Gnoevih V.V. Disfynkcii pylmo-kardialnoi sistemi pri tabakokyrenii y lic molodogo vozrasta i hronicheskie obstryktivnie zabolevaniya lyogkih // Avtoref. diss. na soiskanie ych. st. doktora med. nayk, Ylyanovsk, 2007.-41 str.;


14.Gnoevih V.V. Matematicheskoe modelirovanie rannih nikotinassociirovannih disfynkcii pylmo-kardialnoi sistemi na nachalnih etapah razvitiya HOBL // Pylmonologiya, 2007.-№2.- 63-7;


15. Gnoevih V.V. Hronicheskaya obstryktivnaya bolezn lyogkih. Izdanie dlya praktikyushih vrachei i issledovatelei: monografiya.-Ylyanovsk: YlGY, 2007.-ISBN 978-5-88866-276-2.-174 str.;


16. Gnoevih V.V. Nozologicheskie posledstviya tabakokyreniya sredi lic molodogo vozrasta/V.V. Gnoevih, V.A. Semyonov, A.U. Smirnova, E.A. Shalashova, L.A. Besova, A.A. Kypriyanov, M.U. Zverev, R.M. Hairetdinova // Vestnik novih medicinskih tehnologii, 2008.-t. XV.- №2.-110-12;


17.Gnoevih V.V. Disfynkcii kardiorespiratornoi sistemi pri tabakokyrenii y lic molodogo vozrasta/V.V. Gnoevih, S.P. Grigorev, O.V. Aleksandrov, V.A. Semyonov, A.U. Smirnova, A.A. Kypriyanov, R.M. Hairetdinova // Rossiiskii medicinskii jyrnal, 2008.-№4.-13-7;


18.Gnoevih V.V. Disfynkcii pylmokardialnoi sistemi y lic molodogo vozrasta v processe adaptacii k tabakokyreniu // Klinicheskaya fiziologiya krovoobrasheniya, 2008.-№2.-53-62;


19. Golovochesova G.A. Analiz osnovnih prichin nekontroliryemogo techeniya bronhialnoi astmi // Sibirskii medicinskii jyrnal, 2009, № 4.-128-30;


20.Grippi M.A. Patofiziologiya legkih: Per. s angl. Pod red. U.V. Natochina.-M.: Binom; 1997.109-53;


21.Emelyanov A.V., Fedoseev G.B., Sergeeva G.R., Ivanova N.I., Zibrina T.M. i dr. Rasprostranennost bronhialnoi astmi i allergicheskogo rinita sredi vzroslogo naseleniya Sankt-Peterbyrga. // Allergologiya. 2002. №2.-10-5;


22. Zaridze D.G. Kyrenie - osnovnaya prichina visokoi smertnosti rossiyan/ D.G. Zaridze, R.S. Karpov, S.M. Kiseleva i dr. // Vestnik RAMN, 2002.- №9.-40-5;


23. Zdorove lyogkih v Evrope»: fakti i cifri. Adaptirovannaya versiya «White Book»/per. A.G. Chychalina, N.S. Antonova, E. Koryaginoi, 2003;


24.Ivchik T.V. Faktori riska hronicheskoi obstryktivnoi bolezni lyogkih/ T.V. Ivchik, A.N. Kokosov, E.D. Yanchina i dr. // Pylmonologiya, 2003.-t. 13.-№3.-6-15;


25.Ivanov A.F., Chernyak B.A. Pokazateli kontrolya bronhialnoi astmi i ih vzaimosvyaz s nespecificheskoi giperreaktivnostu bronhov y molodih bolnih // Pylmonologiya, 2007.-№5.-19-23;


26.Karpyshkina A.V., Geppe N.A., Kondurina E.G., Korostovcev D.S, Malahov A.B. i dr. Mnogocentrovoe otkritoe randomizirovannoe kliniko-ekonomicheskoe issledovanie razlichnih rejimov farmakoterapii pri lechenii srednetyajeloi i tyajeloi bronhialnoi astmi y detei // Allergologiya, 2004.-№3.-24-32;


27. Knyajeskaya N.P. Osnovnie principi diagnostiki, klassifikacii i lecheniya bronhialnoi astmi // Consillium-medicum, 2006.-t. 8.-№3;


28.Knyajeskaya N.P. Legkaya persistiryushaya astma: voprosi diagnostiki, lecheniya i kontrolya // Atmosfera. Pylmonologiya i allergologiya, 2006.-№4.-26-30;


29.Kompleksnoe lechenie tabachnoi zavisimosti i profilaktika hronicheskoi obstryktivnoi bolezni lyogkih, vizvannoi kyreniem tabaka. Metodicheskie rekomendacii Ministerstva zdravoohraneniya i socialnogo razvitiya RF №2002/154. M., 2003;


30.Klinicheskie rekomendacii. Bronhialnaya astma. Pod red. akademika RAMN Chychalina A.G. Moskva: Atmosfera, 2008.-224;


31. Kycenko S. A Osnovi toksikologii, 2003.-t. 4.-119;


32. Leshenko I.V. Rasprostranennost bronhialnoi astmi v Sverdlovskoi oblasti// Pylmonologiya, 2001.- 2.- 50-5;


33.Lygovskaya S.A., Pochtar M.E., Dolgov V.V. Gematologicheskie analizatori. Interpretaciya analizov krovi. Metod. rekomendacii. M.: «Triada», 2007.-17-103;


34. Nonikov V.E. Hronicheskaya obstryktivnaya bolezn lyogkih (HOBL): diagnostika i lechenie // Consilium Medicum, 2004.-t.6.-№1;


35. Nonikov V.E. Hronicheskaya obstryktivnaya bolezn lyogkih: terapiya pri stabilnom techenii // Consilium Medicum, 2006.-t.8.-№3.-66-70;


36.Ogorodova L. M., Deev I. A., Selivanova P. A. GINA 2006: Kontrol astmi kak osnovnaya cel lecheniya i kriterii effektivnosti terapii // Pylmonologiya, 2007. – № 6.– 42 – 45.


37.Privalova E.V., Vavilova T.V., Kyzybova N.A. Morfofynkcionalnie harakteristiki eritrocitov y kyrilshikov s obstryktivnoi boleznu legkih // Pylmonologiya, 2008.- №6.- 48 -52;


38.Rakita D.D. Vliyanie kyreniya na techenie hronicheskoi obstryktivnoi bolezni lyogkih // Diss. na soiskanie ych. st. kand. med.nayk, Ryazan, 2004.-124 s.;


39.Rydkevich M.V. stohasticheskaya imitacionnaya model odnogo mehanizma pylmo-kardialnoi sistemi. Diss. na soiskanie ych. st. kand. f.-m.n. Ylyanovsk, 2005.-104s.;


40.Sinopalnikov A.I. Infekcionnoe obostrenie hronicheskoi obstryktivnoi bolezni lyogkih/A.I. Sinopalnikov, A.G. Romanovskih // Atmosfera. Pylmonologiya i allergologiya, 2006.-№3.-15-22;


41. Soodaeva S.K. Okislitelnii stress i antioksidantnaya terapiya pri zabolevaniyah organov dihaniya // Pylmonologiya, 2006.-5.-122-26;


42. Soodaeva S.K. Oksidantnie i antioksidantnie sistemi legkih pri hronicheskih obstryktivnih zabolevaniyah. V kn.: Hronicheskie obstryktivnie bolezni legkih. M.: «Binom»; 1998.-92–110;


43. Soodaeva S.K., Lisica A.V., Kybisheva N.I. i dr. Perspektivi primeneniya antioksidantov v klinike vnytrennih boleznei. «Atmosfera», 2004; 1(12): 55–6;


44. Yest Dj. Fiziologiya dihaniya. Osnovi.-M.-«Mir», 1988.-200 s.;


45.Fedoseev G.B., Trofimov V.I. Bronhialnaya astma. SPB.: Nordmedizdat, 2006;


46.Federalnaya celevaya programma «Bronhialnaya astma» 2011-2015 godi). M., 2009;


47. Chychalin A.G. Hronicheskie obstryktivnie bolezni lyogkih. M.: Binom, 1999.-512 s.;


48. Chychalin A.G. Prakticheskoe rykovodstvo po lecheniu tabachnoi zavisimosti/ A.G. Chychalin, G.M. Saharova, K.U. Novikov // RMJ, 2001.-t.9.-№21.-904-11;


49.Chychalin A.G., Coi A.N., Arhipov V.V., Gavrishina E.E. Bronhialnaya astma v Rossii: rezyltati nacionalnogo issledovaniya kachestva medicinskoi pomoshi bolnim bronhialnoi astmoi // Pylmonologiya, 2006, №6.-94-102;


50.Coi A.N., Arhipov V.V., Chapyrin S.A. Farmakoekonomicheskoe issledovanie novoi koncepcii primeneniya simbikorta y bolnih bronhialnoi astmoi // Pylmonologiya, 2007.-№3.-34- 40;


51. Shalashova E.A. Diagnostika rannih izmenenii fynkcionalnogo sostoyaniya kardio- respiratornoi sistemi y bolnih bronhialnoi astmoi //Avtoreferat diss. na soiskanie ych. stepeni k. m. n., Ylyanovsk, 2006.-24 str.;


52.Shmidt R. Fiziologiya cheloveka. Per. s angl. pod red. Kostuka P.G./R. Shmidt, G. Tevs. M.: «Mir», 1996;


53. Asthma. European Respiratory Monograph 23/Edited by Chung F., Fabbri L.M., European Respiratory Society J., 2003.-V. 8.-458 pp.;


54. Bakke P.S. Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: A Norwegian Community Study/ P.S. Bakke, R. Hanoa, A. Gulsvik // Am. J. Epidemiol., 1995.-141.-1080-88;


55. Baraldi E., Azzolin N.M., Biban P., Zacchello F. Effect of antibiotic therapy on nasal nitric oxide concentration in children with acute sinusitis // Am. J. Respir. Crit Care Med., 1997.-155.-1583– 1680;


56. Barnes P. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids// Eur Respir J, 2002.-19.-182–91;


57. Bateman E.D., Boushey H.A., Bousquet J., Busse W.W., Clark T.J., Pauwels R.A., et al. Can guideline_defined asthma control be achieved? The Gaining Optimal Asthma ControL study // Am. J. Respir. Crit. Care Med., 2004.-170(8).-836-44;


58. Bisgaard H., Loland L., Oj J.A. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast // Am. J. Respir. Crit. Care Med., 1999.- 160.-1227–231;


59. Beasley R. The Global Burden of Asthma Report, Global Initiative for Asthma (GINA). Available from http://www.ginasthma.org, 2004;


60.Beckman J.S. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly/ J.S. Beckman, W.H. Koppenol // Am. J. Physiol., 1996.-271.-1432–37;


61. Boulet L-P, Boulet V, Milot J. How should we quantify asthma control? // Chest, 2002.-122.-2217- 23;


62. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., Vignola A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling // Am. J. Respir. Crit. Care Med., 2000.-161(5):1720-45;


63. Boychuk R.B ., Yamamoto L.G, De Mesa C.J., Kiyabu K.M. Correlation of initial emergency department pulse oximetry values in asthma severity classes (steps) with the risk of hospitalization // Am. J. Emerg. Med., 2006 Jan.-24(1).-48-52;


64. Bowler R.P. The role of oxidative stress in chronic obstructive pulmonarydisease/ R.P. Bowler, P.J. Barnes, J.D. Crapo // J. COPD, 2004.-2.-255–77;


65. Brannan J.D. Bronchial hyperresponsiveness in the assessment of asthma control: Airway hyperresponsiveness in asthma: its measurement and clinical significance // Chest, 2010.-138(2 Suppl).-11S-7S;


66.Campbell J.D., Blough D.K., Sullivan S.D. Comparison of guideline-based control definitions and associations with outcomes in severe or difficult-to-treat asthma // Ann. Allergy Asthma Immunol, 2008.-101.-474–81;


67. Cerveri I., Accordini S., Corsico A., et al. Chronic cough and phlegm in young adults // Eur. Respir. J., 2003.-22.-13–417;


68. Chalmers G.W., Macleod K.J., Little S.A., Thomson L.J., McSharry C.P., Thomson N.C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma // Thorax, 2002.-57.-226– 30;


69. Chalmers G.W., Macleod K.J., Little S.A., Thomson L.J., McSharry C.P., Thomson N.C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma // Thorax, 2002.-57.-226– 30;


70. Chandra R. The Effects of Cigarette Smoking on Anesthesia // Anesth. Prog., 2000.- 47.-143-50;


71. Chaudhuri R., Livingston E., McMahon A.D., Thomson L., Borland W., Thomson N.C. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma // Am. J. Respir. Crit. Care Med., 2003.-168.-1308–11;


72. Coburn R.F. Carbon monoxide toxicity // In Fahri L.E., Tenney S.M. (eds.) Handbook of Physiology, Sect. 3: The Respiratory System, Vol. IV. Bethesda. Amer. Physiology Soc., 1987.- 176-94;


73. Cohn L., Elias J.A., Chupp G.L. Asthma: mechanisms of disease persistence and progression // Ann. Rev. Immunol., 2004.-22.-789-815;


74. Convery R., Leitch D., Bromly C., Ward R., Bartlett G., Hendrick D. Effect of inhaled fluticasone proprionate on airway responsiveness in treatment-naive individuals: a lesser benefit in females // Eur. Respir. J., 2000.-15.-19–24;


75. Coultas D. Passive smoking and risk of adult asthma and COPD: an update // Thorax, 1998.-53.-381- 87;


76.Davidson J.A.H., Hosie H.E. Limitations of pulse oximetry: respiratory insufficiency - a failure of detection // BMJ, 1993.-307.-372-73;


77.Dixon A.E. Asthma in American Indian adults: the Strong Heart Study // Chest, 2007.-131(5).- 1323-30;


78.Ehrich R.I. Risk factors for childhood asthma and wheezing. Importance of maternal and household smoking/ R.I. Ehrich, D. Toit, E. Jordaan et al. // Am. J. Respir. Crit. Care Med., 1996.-154.-681-8;


79.Eggleston P.A. The environment and asthma in US inner cities // Chest, 2007; 132(5 Suppl)/- 782-8;


80. Environmental tobacco smoke: a hazard to children. American Academy of Pediatrics Committee on Environmental Health // Pediatrics, 1997.-99.-639-42;


81. Fagerstrom K. O./K.O. Fagerstrom, U. Sawe // Cardiovasc. Risk Factor, 1997.-Vol. 6.-№3.- 135


82. Fearnley S.J., Manners J.M. Pulse oximetry artifact in a patient with a right ventricular myxoma // Anaesthesia, 1993.-48(1).-87-8;


83.Ferrence R. Protecting children from passive smoking/R. Ferrence, M.J. Ashley // BMJ, 2000.-321.- 310-311;


84. Gerald L.B. Changes in environmental tobacco smoke exposure and asthma morbidity among urban school children // Chest, 2009.-135(4).-911-6;


85.Gilliland F.D. Maternal smoking during pregnancy, environmental tobacco smoke exposure and childhood lung function/F.D. Gilliland, K. Berhane, R. McConnell et al. // Thorax, 2000.-55.-271- 276;


86. Godtfredsen N.S. Changes in smoking habits and risk of asthma: a longitudinal population based study/N.S. Godtfredsen, P. Lange, E. Prescott et al. // Eur. Respir. J., 2001.-18.-549-54;


87. Groneberg D.A., Quarcoo D., Frossard N., Fischer A. Neurogenic mechanisms in bronchial inflammatory diseases // Allergy, 2004.-59(11).-1139.-52;


88. Horváth I ., Donnelly L.E., Kiss A., Paredi P., Kharitonov S.A., Barnes P.J. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress // Thorax, 1998 Aug.-53(8).-668- 72;


89. Higenbottam T.W ., Feyeraband C., Clark T.J. Cigarette smoking in asthma // Br. J. Dis. Chest, 1980 Jul.-74(3).-279-84;


90. Hutton P., Clutton-Brock T. The benefits and pitfalls of pulseoximetry // BMJ, 1993.-307.-457- 458;


91. Ilowite J., Bennett W., Sheetz M., Groth M., Nierman D. Permeability of the bronchial mucosa to 99mTc-DTPA in asthma // Am Rev Respir Dis, 1988.-139.-1139–43;


92. James A. Airway remodeling in asthma // Curr Opin Pulm Med, 2005.-11(1).-1.-6;


93.Jarvis M.J. Expired air carbon monoxide: a simple breath test of tobacco smoke intake/ M.J. Jarvis, M.A. Russel, Y. Saloojee // BMJ, 1980.-281.-484-5;


94. Jindal S.K. The relationship between tobacco smoke & bronchial asthma/ S.K. Jindal, D.Gupta // Indian J. Med. Res., 2004.-Vol. 120(5).-443-53;


95.Kaiser H., Schoetzau A., Flammer J. Blood flow velocity in the extraocular vessels in chronic smokers // Br. J. Ophthalmol., 1997.-81.-133–5;


96. Kharitonov S.A. Acute and chronic effects of cigarette smoking on exhaled nitric oxide/S.A. Kharitonov, R.A. Robbins, D. Yates et al. // Am. J. Respir. Crit. Care Med., 1995.-152(2).-609-12;


97.Kerstens H.A.M. Decline of EFV1 by age and smoking status: facts, figures an fallacies/H.A.M. Kerstens, B. Rijcken, J.P. Schouten et al. // Thorax, 1997.-52.-820-7;


98.Ko F.W., Wang H.Y., Wong G.W., Leung T.F., Hui D.S., Chan D.P., et al. Wheezing in Chinese schoolchildren: disease severity distribution and management practices, a community_based study in Hong Kong and Guangzhou // Clin. Exp. Allergy, 2005.-35(11).-1449-56;


99. Kogevinas, Anto M., Soriano J.M., Tobia A. The risk of asthma attributable to occupantional exposures: a population based study in Spain (Spanish Group of the Europian Asthma Study) // Am. J. Resp. and Crit. Care Med., 1996.-154.-137-43;


100. Kelly A.M., McAlpine R., Kyle E. How accurate are pulse oximeters in patients with acute exacerbations of COPD? // Resp. Med., 2001.-95.-336–40;


101. Kuschner W.G. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults/W.G. Kuschner, A. D'Alessandro, H. Wong et al. // Eur. Respir. J., 1996.-9(10).-1989-94;


102. Lai C.K., De Guia T.S., Kim Y.Y., Kuo S.H., Mukhopadhyay A., Soriano J.B., et al. Asthma control in the Asia_Pacific region: the Asthma Insights and Reality in Asia_Pacific Study // J. Allergy Clin. Immunol., 2003.-111(2).-263-8;


103. Lange P., Parner J., Vestbo J., Schnohr P., Jensen G. A 15 year follow-up study of ventilatory function in adults with asthma // N Engl J Med, 1998.-339.-1194–200;


104. Laustiola K., Lassilia R., Kaprio J., Koskenvuo M. Decreased beta-adrenergic receptor density and catecholamine response in male cigarette smokers: a study of monozygotic twin pairs discordant for smoking // Circulation, 1988.-78.-1234–40;


105. Lenney W. The burden of pediatric asthma // Pediatr Pulmonol Suppl, 1997.-15.-13-6;


106. Levy M.L. Guideline-defined asthma control: a challenge for primary care // Eur. Respir., 2008.- 31.-229–31;


107. Lee P.J., Alam J., Sylvester S.L., Inamdar N., Otterbein L., Choi A.MK. Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury // Am. J. Respir. Cell Mol. Biol., 1996.-14.- 556.-68;


108. Lindberg S., Cervin A., Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis // Acta Otolaryngol., 1997.-117.-113–17;


109. Lindstrom M. Smoking, respiratory symptoms and diseases/ M. Lindstrom, J. Kotaniemi, E. Jonson et al. // Chest, 2001.-119.-852–861;


110. Mancuso C.A. Patient-reported and physician-reported depressive conditions in relation to asthma severity and control // Chest, 2008.- 133(5).- 1142-8;


111. Masoli M., Fabian D., Holt S., Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report // Allergy, 2004.-59(5).-469-78;


112. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur. J. Pharmacol., 2001.- 429.-195–207;


113. Mannino D.M. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity // Chest, 2002.-5(Suppl).-121S-6S;


114. Management of Chronic Obstructive Pulmonary Disease Eur. Respir. Monograph 38/Edited by Siafakas N.M. // European Respiratory Society J, 2006.-V. 11.-475 pp.;


115.Maneechotesuwan K. Loss of control of asthma following inhaled corticosteroid withdrawal is associated with increased sputum interleukin-8 and neutrophils // Chest, 2007.-132(1).-98-105;


116.Miller A.L., Lukacs N.W. Chemokine receptors: understanding their role in asthmatic disease // Immunol Allergy Clin. North. Am., 2004.-24(4).-667-83;


117.Moyle J.T.B. Pulseoximetry. Principles and Practice Series. Editors: Hahn C.E.W. and Adams A.P. // BMJ Publishing, London, 1994;


118.Montuschi P. Isoprostanes: markers and mediators of oxidative stress/ P. Montuschi, P.J. Barnes, L.J. Roberts // FASEB J., 2004.-18.-1791–800;


119.Nafstad P., Kongerud J., Botten G., Hagen J.A., Jaakkola J.J. The role of passive smoking in the development of bronchial obstruction during the first 2 years of life // Epidemiology, 1997.-8(3).-


120.Nathan RA, Sorkness CA, Kosinski M, Schatz M, et al. development of asthma control test: a survery for assessing asthma control // J Allergy and Clinical Immunology, 2004.- 113. -59-65;


121.Neffen H., Fritscher C., Schacht F.C., Levy G., Chiarella P., Soriano J.B., et al. Asthma control in Latin America: the Asthma Insights and Reality in Latin America (AIRLA) survey // Rev. Panam Salud Publica, 2005.-17(3).-191-7;


122. Newman R.B. The effect of active and passive household cigarette smoke exposure on pregnant women with asthma // Chest .-2010.-137(3).- 601-8;


123.Paredi P., Leckie M.J., Horvath I., Allegra L., Kharitonov S.A., Barnes P.J. Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma // Eur Respir J, 1999.-13.-48-52;


124.Pellegrino R.. Assessing the reversibility of airway obstruction/ R. Pellegrino, J.R. Rodarte, V. Brusasco // Chest, 1998.-114.-1607-12;


125.Pedersen B., Dahl R., Karlstrom R., Peterson C., Venge P. Eosinophil and neutrophil activity in asthma in one-year trial with inhaled budesonide // Am. J. Respir. Crit. Care Med., 1996.-153.- 1519–29;


126.Piipari R.. Smoking and asthma in adults/ R. Piipari, J.J.K. Jaakkola, N.J Jaakkola et al. // Eur. Respir. J., 2004.-24(5).-734-39;


127.Rabe K.F., Vermeire P.A., Soriano J.B., Maier W.C. Clinical management of asthma in 1999: the Asthma Insights and Reality in (AIRE) Study // Eur. Respir. J., 2000.-16.- 802–7;


128. Rahman I , Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers // Am. J. Respir. Crit . Care Med ., 1996 Oct.-54(4 Pt 1).-1055-60;


129. Ramírez-Prieto MT , García-Río F, Villamor J. Role of oxidative stress in respiratory diseases and its monitoring // Med Clin (Barc), 2006 Sep 16.-127(10).-386-96;


130. Ramsdale E. H., Morris M. M., Roberts R. S., Hargreave F. E. Asymptomatic bronchial hyperresponsiveness in rhinitis // J. Allergy Clin. Immunol, 1985.- 75.- 73-7;


131.Robbins R.A., Barnes P.J., Springall D.R., et al. Expression of inducible nitric oxide in human lung epithelial cells // Biochem. Biophys. Res. Commun., 1994.-203.-209–18;


132.Sadowska A.M., van Overveld F.J., Gorecka D. et al. The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant // Respir. Med., 2005.-99.-241–49;


133. Saetta M. CD8zT-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease/M. Saetta, A. Di Stefano, G. Turato, et al. // Am. J. Respir. Crit. Care Med., 1998.-157.- 822–826;


134.Sinex, J. Pulse oximetry: principles and limitations // Am J Emerg Med., 1999.-17(1).-59–67;


135.Siroux V, Pin I, Oryszcyn MP, Le Moual N, Kauffmann F. Relationships of active smoking to asthma and asthma severity in the EGEA study // Eur. Respir. J., 2000.-15.-470–77;


136.Shatz M., Zeigert R.S., Vollmer W.M. Predictors of future long-term asthma control // J. Allergy and Clinical Immunology, 2006.-118.-1048;


137.Sherwood N. Effects of nicotine on human psychomotor performance // Human Psychopharmacology.: Clinical and Experimental, 1993.-Vol. 8.-155-84;


138.Soubani A.O. Noninvasive monitoring of oxygen and carbon dioxide // Am. J. Emerg. Med., 2001.- 19(2).-141–46;


139. Soyseth V., Postnatal maternal smoking increases the prevalence of asthma but not of bronchial hyperresponsiveness of atopy of their children/ V. Soyseth, J. Kongerud, J. Boe // Chest, 1995.- 107(2).-389-94;


140. Stoneham M.D.,Saville G.M.,Wilson I.H. Knowledge about pulse oximetry among medical and nursing staff // Lancet, 1994.-334.-1339-42;


141. Tillie-Leblond I.,Gosset P., Tonnel A.B. Inflommantory events in severe acute asthma // Allergy, 2005.- V.60.- 1.- 23-9;


142.Thomson N.C., Chaudhuri R., Livingston E. Asthma and cigarette smoking // Eur. Respir J, 2004.- 24.-822-33;


143. Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities // Curr Opin Pulm Med, 2009.-15.-39–45;


144.Trofor A. Health disorders related to tobacco use and passive smoking // ERS Learning Resources: Smoking cessation, Bucharest, 2004.-http://www.ersnet.org/ers/lr/browse/default.aspx?id=1848;


145.Trofor A. Polyaddictions Part I // ERS Learning Resources: Smoking cessation, Bucharest, 2004. - http://www.ersnet.org/ers/lr/browse/default.aspx?id=1848;


146.Van de Louw A./A. Van de Louw , C. Cracco, C. Cerf et al. // Intens. Care Med.-2001.-27.-1606-13;


147.Wahlgren D.R. Involuntary smoking and asthma/D.R. Wahlgren, M.F. Hovell, E.O. Meltzer et al. // Curr. Opin. Pulm. Med., 2000.-6.-31-6;


148.Weitzman M. Maternal smoking and childhood asthma/ M. Weitzman, S. Gortmaker, D.K. Walker et al. // Pediatrics, 1990.-85.-505-11;


149.Willis D, Moore AR, Frederick R,Willoughby DA. Heme oxygenase: a novel target for the modulation of the inflammatory response // Nature Med, 1996.-2.-87-90;


150.Woodcock AA, Bagdonas A, Boonsawat W, Gibbs MR, Bousquet J, Bateman ED. Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone // Prim Care Respir J, 2007.-16.-155–161;


151.Yang S.R., Wright J., Bauter M., Seweryniak K., Kode A., Rahman I. Sirtuin regulates cigarette smoke–induced pro–inflamotory mediator release via RelA/p65 NF–kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging // Am. J Physiol Lung Cell Mol Physiol, 2007.- 292.-567–76;


152. Zayasu K , Sekizawa K, Okinaga S, Yamaya M, Ohrui T, Sasaki H. Increased carbon monoxide in exhaled air of asthmatic patients // Am J Respir Crit Care Med., 1997 Oct.-156(4 Pt 1).-1140-3.



Свидетельство о регистрации сетевого электронного научного издания N 077 от 29.11.2006
Журнал основан 16 ноября 2000г.
Выдано Министерством РФ по делам печати, телерадиовещания и средств массовых коммуникаций
(c) Перепечатка материалов сайта Medline.Ru возможна только с письменного разрешения редакции

Размещение рекламы

Rambler's Top100